Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Issue: Jan/Feb 2009 - Compounding for Pediatrics
View All Articles in Issue
Page(s): 14-18
Download in electronic PDF format for $75
Abstract: This report is the first to replicate the earlier findings of Standing et al and validates the inadequacy of reporting of dosage forms used in pediatric drug trials. Journal authors should provide and journal editors should require adequate dosage form information for published reports of pediatric drug trials. We also recommend that compounding pharmacists provide detailed compounding instructions to assure that extemporaneously compounded formulations can be reliably reproduced, and that quality-control data be provided to support formulation stability. Until the problem of insuffi cient information is addressed, replication of many pediatric drug trials is impossible, calling into question their reliability and validity.
Related Keywords:
children, dosage forms, clinical drug trials, journals
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
|
Jan/Feb 2009
Pg. 14-18
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
|
Nov/Dec 2022
Pg. 516-521
|
Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery
Rachmawati Putriana
|
Jan/Feb 2023
Pg. 24-29
|
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Fassett William E
|
Nov/Dec 2003
Pg. 441-447
|
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
|
Nov/Dec 2014
Pg. 479-484
|
PreScription: A New Dosage Form
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 356
|
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 312-322
|
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
|
Nov/Dec 2009
Pg. 498-505
|
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder
Gupta Vishnu D
|
Sep/Oct 2003
Pg. 386-388
|
Lollipops: The Evolution of a Dosage Form
Mason Dave, Fields Shannon
|
May/Jun 2002
Pg. 178-179
|
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Vu Nicole
|
Mar/Apr 2007
Pg. 145-148
|
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
|
Jul/Aug 2008
Pg. 372-374
|
Pediatric Compounding: Coloring Outside the Lines
Preckshot John
|
Jan/Feb 2001
Pg. 6-8
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 127-130
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007
Pg. 220-225
|
Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 389-396
|
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
|
Sep/Oct 2021
Pg. 364-371
|
Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting
McElhiney Linda F
|
Jan/Feb 2010
Pg. 32-38
|
Return to Top |